Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Reduced Transplacental Transfer of Antimalarial Antibodies in Kenyan HIV-Exposed Uninfected Infants.

Ray JE, Dobbs KR, Ogolla SO, Daud II, Vulule J, Sumba PO, Rochford R, Dent AE.

Open Forum Infect Dis. 2019 May 20;6(6):ofz237. doi: 10.1093/ofid/ofz237. eCollection 2019 Jun.

2.

Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing.

Dolton MJ, Mikus G, Weiss J, Ray JE, McLachlan AJ.

J Antimicrob Chemother. 2014 Jun;69(6):1633-41. doi: 10.1093/jac/dku031. Epub 2014 Feb 18.

PMID:
24554646
3.

An audit of a therapeutic drug monitoring service for allopurinol therapy.

Kannangara DR, Ramasamy SN, Ray JE, Jones G, Graham GG, Williams KM, Day RO.

Ther Drug Monit. 2013 Dec;35(6):863-6. doi: 10.1097/FTD.0b013e318299920a.

PMID:
24263644
4.

Telaprevir and boceprevir: a potential role for therapeutic drug monitoring.

Dolton MJ, Ray JE, McLachlan AJ.

Ther Drug Monit. 2013 Jun;35(3):414-5. doi: 10.1097/FTD.0b013e318285e87c. No abstract available.

PMID:
23670484
5.

Intraperitoneal voriconazole in a patient with Aspergillus peritoneal dialysis peritonitis.

Roberts DM, Kauter G, Ray JE, Gillin AG.

Perit Dial Int. 2013 Jan-Feb;33(1):92-3. doi: 10.3747/pdi.2012.00023. No abstract available.

6.

Comparing dose prediction software used to manage gentamicin dosing.

Wong C, Kumar SS, Graham GG, Begg EJ, Chin PK, Brett J, Ray JE, Marriott DJ, Williams KM, Day RO.

Intern Med J. 2013 May;43(5):519-25. doi: 10.1111/imj.12067.

PMID:
23279297
7.

Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients.

Brett J, Chong O, Graham GG, Ray JE, Marriott D, Williams KM, Day RO.

Ther Drug Monit. 2013 Feb;35(1):133-6. doi: 10.1097/FTD.0b013e318275fe69.

PMID:
23188182
8.

Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.

Dolton MJ, Ray JE, Chen SC, Ng K, Pont L, McLachlan AJ.

Antimicrob Agents Chemother. 2012 Nov;56(11):5503-10. doi: 10.1128/AAC.00802-12. Epub 2012 Aug 13.

9.

Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.

Dolton MJ, Ray JE, Chen SC, Ng K, Pont LG, McLachlan AJ.

Antimicrob Agents Chemother. 2012 Sep;56(9):4793-9. doi: 10.1128/AAC.00626-12. Epub 2012 Jul 2.

10.

A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults.

Carey D, Pett SL, Bloch M, Wand H, MacRae K, Beileiter K, Ray JE, Boyd MA, Emery S, Cooper DA.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):143-9. doi: 10.1097/QAI.0b013e318252f97e.

PMID:
22421745
11.

Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.

Dolton MJ, Ray JE, Marriott D, McLachlan AJ.

Antimicrob Agents Chemother. 2012 Jun;56(6):2806-13. doi: 10.1128/AAC.05900-11. Epub 2012 Mar 5. Review.

12.

Clinical pharmacokinetics of metformin.

Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM.

Clin Pharmacokinet. 2011 Feb;50(2):81-98. doi: 10.2165/11534750-000000000-00000. Review.

PMID:
21241070
13.

Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development.

Norris RL, Martin JH, Thompson E, Ray JE, Fullinfaw RO, Joyce D, Barras M, Jones GR, Morris RG.

Ther Drug Monit. 2010 Oct;32(5):615-23. doi: 10.1097/FTD.0b013e3181ea3e8a.

PMID:
20683393
14.

Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia.

Ray JE, Garcia J, Jurisicova A, Caniggia I.

Cell Death Differ. 2010 May;17(5):846-59. doi: 10.1038/cdd.2009.167. Epub 2009 Nov 27.

15.
16.

Mild clinical toxicity and dose-dependent pharmacokinetics following acute lopinavir/ritonavir poisoning in a HIV-positive patient.

Roberts DM, Ray JE, Buckley NA.

AIDS. 2008 Mar 30;22(6):792-3. doi: 10.1097/QAD.0b013e3282f4a0dd. No abstract available.

PMID:
18356614
17.
18.

Hypoxic switch in mitochondrial myeloid cell leukemia factor-1/Mtd apoptotic rheostat contributes to human trophoblast cell death in preeclampsia.

Soleymanlou N, Jurisicova A, Wu Y, Chijiiwa M, Ray JE, Detmar J, Todros T, Zamudio S, Post M, Caniggia I.

Am J Pathol. 2007 Aug;171(2):496-506. Epub 2007 Jun 28.

20.

CEDIA mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipients.

Westley IS, Ray JE, Morris RG.

Ther Drug Monit. 2006 Oct;28(5):632-6.

PMID:
17038877
21.

Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic.

Ray JE, Marriott D, Bloch MT, McLachlan AJ.

Br J Clin Pharmacol. 2005 Sep;60(3):291-9.

22.

Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors.

Liang J, Moore RE, Moher ED, Munroe JE, Al-awar RS, Hay DA, Varie DL, Zhang TY, Aikins JA, Martinelli MJ, Shih C, Ray JE, Gibson LL, Vasudevan V, Polin L, White K, Kushner J, Simpson C, Pugh S, Corbett TH.

Invest New Drugs. 2005 Jun;23(3):213-24.

PMID:
15868377
23.

Biological evaluation of cryptophycin 52 fragment A analogues: effect of the multidrug resistance ATP binding cassette transporters on antitumor activity.

Al-Awar RS, Corbett TH, Ray JE, Polin L, Kennedy JH, Wagner MM, Williams DC.

Mol Cancer Ther. 2004 Sep;3(9):1061-7.

24.

Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors.

Al-awar RS, Ray JE, Hecker KA, Joseph S, Huang J, Shih C, Brooks HB, Spencer CD, Watkins SA, Schultz RM, Considine EL, Faul MM, Sullivan KA, Kolis SP, Carr MA, Zhang F.

Bioorg Med Chem Lett. 2004 Aug 2;14(15):3925-8.

PMID:
15225699
25.

1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitors.

Al-awar RS, Ray JE, Hecker KA, Huang J, Waid PP, Shih C, Brooks HB, Spencer CD, Watkins SA, Patel BR, Stamm NB, Ogg CA, Schultz RM, Considine EL, Faul MM, Sullivan KA, Kolis SP, Grutsch JL, Joseph S.

Bioorg Med Chem Lett. 2004 Jun 21;14(12):3217-20.

PMID:
15149678
26.

Synthetic approaches to indolo[6,7-a]pyrrolo[3,4-c]carbazoles: potent cyclin D1/CDK4 inhibitors.

Faul MM, Engler TA, Sullivan KA, Grutsch JL, Clayton MT, Martinelli MJ, Pawlak JM, LeTourneau M, Coffey DS, Pedersen SW, Kolis SP, Furness K, Malhotra S, Al-awar RS, Ray JE.

J Org Chem. 2004 Apr 30;69(9):2967-75.

PMID:
15104433
27.

Cyclosporin C(2) and C(0) concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors.

Ray JE, Keogh AM, McLachlan AJ, Akhlaghi F.

J Heart Lung Transplant. 2003 Jul;22(7):715-22.

PMID:
12873538
28.

A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.

Al-Awar RS, Ray JE, Schultz RM, Andis SL, Kennedy JH, Moore RE, Liang J, Golakoti T, Subbaraju GV, Corbett TH.

J Med Chem. 2003 Jul 3;46(14):2985-3007.

PMID:
12825938
29.

Cyclosporin monitoring in Australasia: 2002 update of consensus guidelines.

Morris RG, Ilett KF, Tett SE, Ray JE, Fullinfaw RO, Cooke R, Cook S.

Ther Drug Monit. 2002 Dec;24(6):677-88.

PMID:
12451282
30.

Structures of three inhibitor complexes provide insight into the reaction mechanism of the human methylenetetrahydrofolate dehydrogenase/cyclohydrolase.

Schmidt A, Wu H, MacKenzie RE, Chen VJ, Bewly JR, Ray JE, Toth JE, Cygler M.

Biochemistry. 2000 May 30;39(21):6325-35.

PMID:
10828945
31.

Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.

Patel VF, Andis SL, Kennedy JH, Ray JE, Schultz RM.

J Med Chem. 1999 Jul 15;42(14):2588-603.

PMID:
10411479
32.

Itraconazole and HIV protease inhibitors: an important interaction.

MacKenzie-Wood AR, Whitfeld MJ, Ray JE.

Med J Aust. 1999 Jan 4;170(1):46-7. No abstract available.

PMID:
10026677
33.

Disposition and metabolism of the sulfonylurea oncolytic agent LY295501 in mouse, rat, and monkey.

Ehlhardt WJ, Woodland JM, Toth JE, Ray JE, Martin DL.

Drug Metab Dispos. 1997 Jun;25(6):701-8.

PMID:
9193871
34.

Sulfonimidamide analogs of oncolytic sulfonylureas.

Toth JE, Grindey GB, Ehlhardt WJ, Ray JE, Boder GB, Bewley JR, Klingerman KK, Gates SB, Rinzel SM, Schultz RM, Weir LC, Worzalla JF.

J Med Chem. 1997 Mar 14;40(6):1018-25.

PMID:
9083492
35.

Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs.

Norman BH, Shih C, Toth JE, Ray JE, Dodge JA, Johnson DW, Rutherford PG, Schultz RM, Worzalla JF, Vlahos CJ.

J Med Chem. 1996 Mar 1;39(5):1106-11.

PMID:
8676346
36.

Cyclosporin A monitoring in Australia: consensus recommendations.

Morris RG, Tett SE, Ray JE.

Ther Drug Monit. 1994 Dec;16(6):570-6.

PMID:
7878696
37.

Mucinous carcinoma--just another colon cancer?

Green JB, Timmcke AE, Mitchell WT, Hicks TC, Gathright JB Jr, Ray JE.

Dis Colon Rectum. 1993 Jan;36(1):49-54. Review.

PMID:
8380140
38.

Ogilvie's syndrome: colonoscopic decompression and analysis of predisposing factors.

Jetmore AB, Timmcke AE, Gathright JB Jr, Hicks TC, Ray JE, Baker JW.

Dis Colon Rectum. 1992 Dec;35(12):1135-42.

PMID:
1473414
39.

Formation of indenesulfonylureas in the metabolism of the anticancer agent sulofenur in rats, monkeys, and humans.

Ehlhardt WJ, Zimmermann JL, Ray JE, Toth JE.

Drug Metab Dispos. 1992 Nov-Dec;20(6):958-61. No abstract available.

PMID:
1362953
40.

Rectal carcinoids: the most frequent carcinoid tumor.

Jetmore AB, Ray JE, Gathright JB Jr, McMullen KM, Hicks TC, Timmcke AE.

Dis Colon Rectum. 1992 Aug;35(8):717-25.

PMID:
1643994
41.

Diminutive colonic polyps: an indication for colonoscopy.

Opelka FG, Timmcke AE, Gathright JB Jr, Ray JE, Hicks TC.

Dis Colon Rectum. 1992 Feb;35(2):178-81.

PMID:
1735321
42.
43.

Calcified mucocele of the appendix presenting as ureteral obstruction.

Risher WH, Ray JE, Hicks TC.

J La State Med Soc. 1991 Nov;143(11):29-31.

PMID:
1753179
44.

Complications associated with ileal pouch-anal anastomosis.

McMullen K, Hicks TC, Ray JE, Gathright JB, Timmcke AE.

World J Surg. 1991 Nov-Dec;15(6):763-6; discussion 766-7.

PMID:
1662842
46.

Colonoscopic screening of asymptomatic patients with a family history of colon cancer.

Baker JW, Gathright JB Jr, Timmcke AE, Hicks TC, Ferrari BT, Ray JE.

Dis Colon Rectum. 1990 Nov;33(11):926-30.

PMID:
2226078
47.

Usefulness of performing colonoscopy one year after endoscopic polypectomy.

Woolfson IK, Eckholdt GJ, Wetzel CR, Gathright JB Jr, Ray JE, Hicks TC, Timmcke AE, Ferrari BT.

Dis Colon Rectum. 1990 May;33(5):389-93.

PMID:
2328628
48.

Results of operation for rectovaginal fistula in Crohn's disease.

Morrison JG, Gathright JB Jr, Ray JE, Ferrari BT, Hicks TC, Timmcke AE.

Dis Colon Rectum. 1989 Jun;32(6):497-9.

PMID:
2791787
49.

Surgical management of anorectal fistulas in Crohn's disease.

Morrison JG, Gathright JB Jr, Ray JE, Ferrari BT, Hicks TC, Timmcke AE.

Dis Colon Rectum. 1989 Jun;32(6):492-6.

PMID:
2791786
50.

Classification of overdose/self-poisoning presentations to an accident and emergency department.

Reilly DK, Ray JE, Day RO, Wodak A, O'Connor D, Thompson J.

Int J Addict. 1987 Oct;22(10):941-55.

PMID:
3692635

Supplemental Content

Support Center